Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer
- Authors
- Kim, E. Y.; Lee, H. Y.; Kim, K. W.; Lee, J. -I.; Kim, Y. S.; Choi, Won-Jun; Kim, J. H.
- Issue Date
- Sep-2018
- Publisher
- SAGE PUBLICATIONS LTD
- Keywords
- Sarcopenia; skeletal muscle; surgery; complication; non-small cell lung cancer; tomography; X-ray computed
- Citation
- SCANDINAVIAN JOURNAL OF SURGERY, v.107, no.3, pp.244 - 251
- Journal Title
- SCANDINAVIAN JOURNAL OF SURGERY
- Volume
- 107
- Number
- 3
- Start Page
- 244
- End Page
- 251
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3406
- DOI
- 10.1177/1457496917748221
- ISSN
- 1457-4969
- Abstract
- Background: Sarcopenia, reduced skeletal muscle mass, is associated with frailty, injuries, and mortality. The purpose of this study was to evaluate the impact of computed tomography-determined sarcopenia on surgical complications and outcomes after resection of non-small cell lung cancer. Methods: For a total 272 non-small cell lung cancer patients that underwent surgery between 2011 and 2016, cross-sectional area of muscle at the third lumbar vertebra (L3) was retrospectively measured using preoperative chest computed tomography images. Sarcopenia was defined as an L3 muscle index of <55cm(2)/m(2) for men and of <39cm(2)/m(2) for women. Clinical characteristics, postoperative complications, disease-free survival, and overall survival of patients with or without sarcopenia were compared. Results: A total of 60.3% (n=164) were male, and mean patient age was 62.99.6years. The prevalence of sarcopenia was 22.4% for all study subjects, 32.9% for men, and 6.5% for women. No significant difference was observed between patients with or without sarcopenia in terms of intensive care unit or hospital stay (p=0.502 and p=0.378, respectively), and the presence of sarcopenia was not associated with postoperative complications. Furthermore, no significant difference was observed between the 3-year disease-free survival rate (74.3% vs 66.7%, p=0.639) or 3-year overall survival rate (83.9% vs 87.7%, p=0.563) of patients with or without sarcopenia. Conclusion: Sarcopenia as determined by preoperative computed tomography does not appear to have a negative impact on surgical outcome or overall survival for resected non-small cell lung cancer patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3406)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.